Kaskela Law LLC is investigating Trevi Therapeutics, Inc. (NASDAQ: TRVI) (“Trevi”) on behalf of the company’s long-term investors.
The investigation seeks to determine whether Trevi and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to investors in connection with recent corporate actions.
Trevi shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at 484-229-0750, or by completing the form on this page, to receive additional information about this investigation and their legal rights and options.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
1234 West Chester Pike, Suite 300
West Chester, PA 19382
484-229-0750